Search Results - "ROBINS, R. A"

Refine Results
  1. 1

    Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A by Nowlan, M. L., Drewe, E., Bulsara, H., Esposito, N., Robins, R. A., Tighe, P. J., Powell, R. J., Todd, I.

    Published in Rheumatology (Oxford, England) (01-01-2006)
    “…Objective. To investigate the levels of the pro-inflammatory cytokines IL-6, TNF-α, IL-1β, IL-8, IL-10 and IL-12p70 in the plasma of patients with TNF…”
    Get full text
    Journal Article
  2. 2

    Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients by DURRANT, L. G, CHAPMAN, M. A, BUCKLEY, D. J, SPENDLOVE, I, ROBINS, R. A, ARMITAGE, N. C

    Published in Cancer Immunology, Immunotherapy (01-10-2003)
    “…This study prospectively correlated the level of expression of CD55 on tumours with 7-year survival in 136 colorectal cancer patients. Patients with tumours…”
    Get full text
    Journal Article
  3. 3

    Monocytes Are Highly Sensitive to Clostridium difficile Toxin A-Induced Apoptotic and Nonapoptotic Cell Death by Solomon, K, Webb, J, Ali, N, Robins, R. A, Mahida, Y. R

    Published in Infection and Immunity (01-03-2005)
    “…In this study we investigated the in vitro responses of peripheral blood mononuclear preparations and purified monocytes to Clostridium difficile toxin A. In…”
    Get full text
    Journal Article
  4. 4

    Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells by Jean-Gilles, L., Braitch, M., Latif, M. L., Aram, J., Fahey, A. J., Edwards, L. J., Robins, R. A., Tanasescu, R., Tighe, P. J., Gran, B., Showe, L. C., Alexander, S. P., Chapman, V., Kendall, D. A., Constantinescu, C. S.

    Published in Acta Physiologica (01-05-2015)
    “…Aims To investigate the regulation of cannabinoid receptors CB1 and CB2 on immune cells by pro‐inflammatory cytokines and its potential relevance to the…”
    Get full text
    Journal Article
  5. 5

    Kinetics of immune cell migration at the human ocular surface by Chan, J H, Amankwah, R, Robins, R A, Gray, T, Dua, H S

    Published in British journal of ophthalmology (01-07-2008)
    “…The conjunctiva has a resident population of intraepithelial and stromal immune cells. These cells play an active part in ocular surface defence and disease…”
    Get more information
    Journal Article
  6. 6

    Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis by Murray, J. C., Heng, Y. M., Symonds, P., Rice, K., Ward, W., Huggins, M., Todd, I., Robins, R. A.

    Published in Journal of leukocyte biology (01-05-2004)
    “…The novel, proinflammatory cytokine endothelial monocyte‐activating polypeptide‐II (EMAP‐II) was first found in tumor cell supernatants. EMAP‐II is closely…”
    Get full text
    Journal Article
  7. 7

    Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients by Damanhouri, L. H., Dromey, J. A., Christie, M. R., Nasrat, H. A., Ardawi, M. S. M., Robins, R. A., Todd, I.

    Published in Diabetic medicine (01-04-2005)
    “…Aims  To determine the prevalence of autoantibodies in sera of Saudi diabetic patients including Type 1 and Type 2 diabetes mellitus (DM) and gestational…”
    Get full text
    Journal Article
  8. 8

    Decreased interferon‐β induced STAT‐4 activation in immune cells and clinical outcome in multiple sclerosis by Tanasescu, R., Midgley, A., Robins, R. A., Constantinescu, C. S.

    Published in Acta neurologica Scandinavica (01-09-2017)
    “…Objectives Interferon‐β (IFN‐β) is used in the treatment of multiple sclerosis (MS). IFN‐β activation of signal transduction and activation of transcription…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis by Braitch, M., Harikrishnan, S., Robins, R. A., Nichols, C., Fahey, A. J., Showe, L., Constantinescu, C. S.

    Published in Acta neurologica Scandinavica (01-04-2009)
    “…Objectives –  To determine whether percentages of CD4+CD25high T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in…”
    Get full text
    Journal Article
  11. 11

    Th17/Th1 phenotype in demyelinating disease by Edwards, L.J., Robins, R.A., Constantinescu, C.S.

    Published in Cytokine (Philadelphia, Pa.) (01-04-2010)
    “…Background: Th17 cells are thought to contribute to the immunopathology of allergic and autoimmune conditions. Their role in multiple sclerosis (MS) pathology…”
    Get full text
    Journal Article
  12. 12

    Immunological aspects of head and neck cancer: Biology, pathophysiology and therapeutic mechanisms by McKechnie, A., Robins, R.A., Eremin, O.

    Published in The surgeon (Edinburgh) (01-08-2004)
    “…Advanced cancer and head and neck cancer, in particular, remains a major clinical challenge with its associated morbidity and inevitable mortality. Local…”
    Get full text
    Journal Article
  13. 13

    Vaccination and malignant disease: Promising therapeutic approach by McKechnie, A., Robins, R.A., Eremin, O.

    Published in The surgeon (Edinburgh) (01-06-2005)
    “…Immunotherapy of cancer is now entering its second century. Much of our understanding of the complex interaction between tumours and the host immune system has…”
    Get full text
    Journal Article
  14. 14

    A Neoadjuvant Clinical Trial in Colorectal Cancer Patients of the Human Anti-Idiotypic Antibody 105AD7, Which Mimics CD55 by Durrant, L G, Maxwell-Armstrong, C, Buckley, D, Amin, S, Robins, R A, Carmichael, J, Scholefield, J H

    Published in Clinical cancer research (01-02-2000)
    “…Thirty-five patients received 105AD7 human anti-idiotype vaccination prior to surgery for colorectal carcinoma. Patients were immunized before and also…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Vaccination therapy in malignant disease by Aloysius, M.M., Robins, R.A., Eremin, J.M., Eremin, O.

    Published in The surgeon (Edinburgh) (01-10-2006)
    “…Improvement in survival among patients with early malignancy is well established in various cancers. However, long-term survival in those with advanced…”
    Get full text
    Journal Article
  17. 17

    Loss of cytomegalovirus‐specific immunological memory in a patient with thymoma by HUISSOON, A. P., DAVIES, G., COX, R. A., SLOPER, C. M. L., THOMSON, B. J., ROBINS, R. A.

    Published in Clinical and experimental immunology (01-08-2002)
    “…SUMMARY Cytomegalovirus (CMV) retinitis is a re‐activation infection associated with severely impaired T cell‐mediated immunity. We describe a patient with…”
    Get full text
    Journal Article
  18. 18

    Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7 by Maxwell-Armstrong, C A, Durrant, L G, Robins, R A, Galvin, A M, Scholefield, J H, Hardcastle, J D

    Published in Gut (01-10-1999)
    “…BACKGROUND The anti-idiotypic monoclonal antibody 105AD7 mimics the tumour associated antigen 791Tgp72, expressed on 70–80% of colorectal cancers. Phase I…”
    Get full text
    Journal Article
  19. 19

    S antigen specific effector T cell activation detected by cytokine flow cytometry by Morgan, J P, Robins, R A, Dua, H S, Tighe, P J

    Published in British journal of ophthalmology (01-05-2002)
    “…Background/aims: Effector T cell activation is particularly important in the initiation of autoimmune uveitis. This pilot study seeks to demonstrate activation…”
    Get full text
    Journal Article
  20. 20

    105Ad7 cancer vaccine stimulates anti‐tumour helper and cytotoxic T‐cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses by Durrant, Lindy G., Buckley, Declan J., Robins, R. Adrian, Spendlove, Ian

    Published in International journal of cancer (01-01-2000)
    “…105AD7 is a human anti‐idiotypic antibody that recognises the binding site of the anti‐tumour antibody 791T/36 and can thereby mimic the CD55 antigen. The…”
    Get full text
    Journal Article